First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

Samuel Cytryn, Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi, Geoffrey Y. Ku, Steven B. Maron, Avni M. Desai, Jessica Yang, Ryan Sugarman, Devika Rao, Zoe Goldberg, Carmelina Charalambous, M. A. Lapshina, Ariel Antoine, Fiona Socolow, Nikhil Trivedi, Marinela Capanu, Hans Gerdes, Mark Schattner, Marc Simmons, Mario E. Lacouture, Viktoriya Paroder, Laura H. Tang, Jinru Shia, David H. Ilson, David B. Solit, Michael F. Berger, Yelena Y. Janjigian